Companies Dominating the Dental Membrane and Bone Graft Substitutes Landscape
- Dentsply Sirona
- Company Overview
- Business Strategy
- Key Product Offerings
- Financial Performance
- Key Performance Indicators
- Risk Analysis
- Recent Development
- Regional Presence
- SWOT Analysis
- Straumann AG
- Zimmer Biomet Inc.
- Biohorizons Inc
- Geistlich Pharma Ag
- Rti Surgicals
- Dentium Co, Ltd.
- Lifenet Health
- Medtronic plc
- Orthogen AG
The dental membrane and bone graft substitutes market companies are engaging in several ongoing trends, including development of bioresorbable membranes and synthetic bone graft substitutes that promote natural bone regeneration while minimizing surgical interventions. Companies are also investing in regenerative medicine-based products, such as growth-factor-infused membranes, to improve clinical outcomes. Some of the companies participating in the market include:
Browse key industry insights with market data tables & charts from the report:
Frequently Asked Questions (FAQ)
In the year 2025, the industry size of dental membrane and bone graft substitutes is estimated at USD 882.77 million.
The dental membrane and bone graft substitutes market size was valued at USD 767.03 million in 2024 and is likely to cross USD 2.37 billion by 2037, registering more than 9.1% CAGR during the forecast period i.e., between 2025-2037. Rising prevalence of oral diseases, increasing geriatric population along with increasing awareness about oral health will boost the market growth.
North America industry is anticipated to dominate majority revenue share of 37% by 2037, owing to surge in the cases of dental problems and injuries along with increasing number of people visiting the dentist in the region.
The major players in the market are Dentsply Sirona, Straumann AG, Zimmer Biomet Inc., Biohorizons Inc, Geistlich Pharma Ag, Rti Surgicals, Dentium Co, Ltd., Lifenet Health, Medtronic plc, Orthogen AG
